Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators want to find a way to reduce or stop patients from coughing at the end of surgery when the breathing tube is taken out. The breathing tube is removed when the participants are waking up from anesthesia, and are at the point when the participants can breathe on your own. In most types of surgery, coughing at this point is common, and does not affect the participants very much, if at all. But for surgery involving the eye or the head and neck, coughing right after surgery can cause bleeding at the site of surgery.
This study will use a short-acting pain drug called remifentanil at the end of surgery to prevent coughing. The investigators will give the participants this medicine for 5 to 30 minutes. The point of the study is to test if using a simple computer program to guide precise delivery of how much of the drug is given to the participants is effective at reducing or preventing coughing.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Remifentanil group | Experimental | Will receive remifentanil bolus and infusion guided by an algorithm |
|
| Control group | Placebo Comparator | Will receive normal saline bolus and infusion guided by the remifentanil algorithm |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Remifentanil | Drug | Receive remifentanil bolus and infusion guided by an algorithm. |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of cough | Notes presence of cough during emergence | Measured from surgical end time to patient transfer out of room, approximetly 30 minutes and up to 45 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Coughing grade | Ranks severity of cough during emergence: cough was graded according to the following scoring guidelines: 0=no cough, 1=slight cough, cough without obvious contraction of the abdomen, 2=moderate cough, strong and sudden contraction of the abdomen lasting for less than 5 seconds and 3=severe cough, strong and sudden contraction of the abdomen sustained for more than 5 seconds. | Measured from surgical end time to patient transfer out of room, approximetly 30 minutes |
Not provided
Inclusion Criteria:
Between the ages of 18 and 80
ASA of 1-3
Undergoing any of the following elective cases:
Will require endotracheal intubation.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Elie Sarraf, MD.CM. | Contact | (802) 847-4259 | elie.sarraf@uvmhealth.org | |
| Alex F Friend | Contact | (802) 847-4259 | Alexander.Friend@uvmhealth.org |
| Name | Affiliation | Role |
|---|---|---|
| Elie Sarraf, MD.CM. | Resident | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| ICF | No | No | Yes | Informed Consent Form | Apr 10, 2018 | May 7, 2018 | ICF_000.pdf |
| Prot | Yes | No | No | Study Protocol | Apr 10, 2018 | May 7, 2018 | Prot_001.pdf |
Not provided
| ID | Term |
|---|---|
| D003371 | Cough |
| ID | Term |
|---|---|
| D012120 | Respiration Disorders |
| D012140 | Respiratory Tract Diseases |
| D012818 | Signs and Symptoms, Respiratory |
| D012816 | Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077208 | Remifentanil |
| D000077330 | Saline Solution |
| ID | Term |
|---|---|
| D011422 | Propionates |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Normal saline |
| Drug |
Receive normal saline bolus and infusion guided by the remifentanil algorithm. |
|
| Extubation time | Time between the termination of the anesthetic and extubation | Measured from termination of the anesthetic to extubation, approximetly 5 minutes and up to 30 minutes |
| Time to recovery | Time between extubation and the ability to perform purposeful movement | Measured from extubation to purposeful movement, approximetly 5 minutes and up to 30 minutes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010880 |
| Piperidines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D000077324 | Crystalloid Solutions |
| D007552 | Isotonic Solutions |
| D012996 | Solutions |
| D004364 | Pharmaceutical Preparations |